Cargando…
Intravenous immunoglobulin in COVID-19 associated Guillain–Barré syndrome in pregnancy
The COVID-19 pandemic has led to a rise in cases of Guillain-Barré syndrome (GBS). This autoimmune sequela is a manifestation of the neurotropism potential of the virus. At present, knowledge regarding the pathophysiology, clinical features, management and outcomes of the condition is still evolving...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118003/ https://www.ncbi.nlm.nih.gov/pubmed/33975846 http://dx.doi.org/10.1136/bcr-2021-242365 |
_version_ | 1783691674066616320 |
---|---|
author | Garcia, Jao Jarro Turalde, Christian Wilson Bagnas, Marjorie Anne Anlacan, Veeda Michelle |
author_facet | Garcia, Jao Jarro Turalde, Christian Wilson Bagnas, Marjorie Anne Anlacan, Veeda Michelle |
author_sort | Garcia, Jao Jarro |
collection | PubMed |
description | The COVID-19 pandemic has led to a rise in cases of Guillain-Barré syndrome (GBS). This autoimmune sequela is a manifestation of the neurotropism potential of the virus. At present, knowledge regarding the pathophysiology, clinical features, management and outcomes of the condition is still evolving. This paper presents the case of a 22-year-old pregnant patient who came in with a history of upper respiratory tract symptoms followed by acroparaesthesia and progressive ascending weakness. She was confirmed to have COVID-19 and GBS and was subsequently managed with intravenous immunoglobulin (IVIg) followed by supportive therapy. To the authors’ knowledge and based on their literature search, this is the first reported case of GBS in a COVID-19 confirmed pregnant patient who received IVIg. |
format | Online Article Text |
id | pubmed-8118003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-81180032021-05-26 Intravenous immunoglobulin in COVID-19 associated Guillain–Barré syndrome in pregnancy Garcia, Jao Jarro Turalde, Christian Wilson Bagnas, Marjorie Anne Anlacan, Veeda Michelle BMJ Case Rep Case Report The COVID-19 pandemic has led to a rise in cases of Guillain-Barré syndrome (GBS). This autoimmune sequela is a manifestation of the neurotropism potential of the virus. At present, knowledge regarding the pathophysiology, clinical features, management and outcomes of the condition is still evolving. This paper presents the case of a 22-year-old pregnant patient who came in with a history of upper respiratory tract symptoms followed by acroparaesthesia and progressive ascending weakness. She was confirmed to have COVID-19 and GBS and was subsequently managed with intravenous immunoglobulin (IVIg) followed by supportive therapy. To the authors’ knowledge and based on their literature search, this is the first reported case of GBS in a COVID-19 confirmed pregnant patient who received IVIg. BMJ Publishing Group 2021-05-11 /pmc/articles/PMC8118003/ /pubmed/33975846 http://dx.doi.org/10.1136/bcr-2021-242365 Text en © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. https://bmj.com/coronavirus/usageThis article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. |
spellingShingle | Case Report Garcia, Jao Jarro Turalde, Christian Wilson Bagnas, Marjorie Anne Anlacan, Veeda Michelle Intravenous immunoglobulin in COVID-19 associated Guillain–Barré syndrome in pregnancy |
title | Intravenous immunoglobulin in COVID-19 associated Guillain–Barré syndrome in pregnancy |
title_full | Intravenous immunoglobulin in COVID-19 associated Guillain–Barré syndrome in pregnancy |
title_fullStr | Intravenous immunoglobulin in COVID-19 associated Guillain–Barré syndrome in pregnancy |
title_full_unstemmed | Intravenous immunoglobulin in COVID-19 associated Guillain–Barré syndrome in pregnancy |
title_short | Intravenous immunoglobulin in COVID-19 associated Guillain–Barré syndrome in pregnancy |
title_sort | intravenous immunoglobulin in covid-19 associated guillain–barré syndrome in pregnancy |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118003/ https://www.ncbi.nlm.nih.gov/pubmed/33975846 http://dx.doi.org/10.1136/bcr-2021-242365 |
work_keys_str_mv | AT garciajaojarro intravenousimmunoglobulinincovid19associatedguillainbarresyndromeinpregnancy AT turaldechristianwilson intravenousimmunoglobulinincovid19associatedguillainbarresyndromeinpregnancy AT bagnasmarjorieanne intravenousimmunoglobulinincovid19associatedguillainbarresyndromeinpregnancy AT anlacanveedamichelle intravenousimmunoglobulinincovid19associatedguillainbarresyndromeinpregnancy |